Speaker: Donald Yance, CN, RH (AHG) This lecture investigates the latest research into Vascular Endothelial Growth Factor (VEGF) as one of the drivers in cancer growth. Biomedicine has made great strides in identifying this pathway and creating drugs to address it, and these will receive a thorough review in this lecture. New research has also brought to light ways in which botanical and nutritional medicine can work in concert with these drugs toward a better outcome with reduced side effects. We also summarize potential predictive biomarkers to determine the risk-to-benefit of the use of these drugs– including pathology tests, blood tests, and some clinical pearls based on observational clues. And finally, we discuss herbal extracts and specific herbal and dietary compounds which can modulate and selectively suppress VEGF.
Related product: The PowerPoint for this recording is available here: 2022 Medicines from the Earth Herb Symposium Book Download (PDF)
Also available in video (for purchase separately on Vimeo).
Continuing Education:
Naturopathic Physicians: This recording has been approved for 1.5 PHARM CME
- Oregon Board of Naturopathic Medicine (OBNM)
Targeting VEGF (Vascular Endothelial Growth Factor): A Main Driver in Cancer Angiogenesis and Growth
- Event: 2022 Medicines from the Earth Herb Symposium
- Product Code: 22ME20
- Availability: In Stock
-
$11.99
Related Products
Tags: cancer, vascular, angiogenesis